SCHEMBL4033144

SCHEMBL4033144

O=C(NCc1ccccc1Cl)C1CCNCC1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.67
CHRM3 P20309 1/20 0.67
ALDH1A1 P00352 3/20 0.58
LMNA P02545 1/20 0.58
PKM P14618 4/20 0.58
TP53 P04637 1/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
GAA P10253 1/20 0.56
EPHX2 P34913 1/20 0.56
PLA2G1B P04054 1/20 0.55
ATG4B Q9Y4P1 1/20 0.55
KDM4E B2RXH2 1/20 0.54
THRB P10828 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
P2RX7 Q99572 2/20 0.53
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467120 0.89 NPC1 (0.66) ALDH1A1LMNAPKMTP53NPC1
SCHEMBL2260332 0.86 CHRM1 (0.61) CHRM1CHRM3GAAEPHX2P2RX7
Bromide SCHEMBL11408063 0.85 CHRM1 (0.60) CHRM1CHRM3GAAEPHX2P2RX7
SCHEMBL13745755 0.84 PKM (0.59) CHRM1CHRM3ALDH1A1LMNAPKM
SCHEMBL13746180 0.84 CHRM1 (0.59) CHRM1CHRM3ALDH1A1LMNATP53
Formic Acid SCHEMBL5073526 0.84 ALDH1A1 (0.60) ALDH1A1LMNAPKMTP53NPC1
SCHEMBL2714814 0.83 CHRM1 (0.53) CHRM1CHRM3ALDH1A1LMNAPKM
SCHEMBL13746003 0.83 PKM (0.56) CHRM1CHRM3ALDH1A1LMNAPKM
SCHEMBL15232889 0.83 CYP2D6 (0.66) ALDH1A1PKMGAAEPHX2MEN1
SCHEMBL30924153 0.82 P2RX7 (0.58) CHRM1CHRM3ALDH1A1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
WO-2009098282-A1 LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY NOVASAID AB (SE) 2009-08-13 WO disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed